vakilspremedia, Author at Microbiome

C. DIFF INFECTION IS EVEN MORE DANGEROUS WHEN IT RECURS Phase 2 Posted on October 18, 2021 (October 21, 2021) by vakilspremedia in For version 2.0
Get the full story of the microbiome Phase 2 Posted on October 8, 2021 (October 21, 2021) by vakilspremedia in For version 2.0
Current Therapeutic Options for Gut Microbiome Restoration Are Limited Phase 2 Posted on October 8, 2021 (October 21, 2021) by vakilspremedia in For version 2.0
Standard of Care and Predominant Risk Factor Phase 2 Posted on October 8, 2021 (January 18, 2022) by vakilspremedia in For version 2.0
Recurrent C. diff Infection Burden Phase 2 Posted on October 8, 2021 (October 21, 2021) by vakilspremedia in For version 2.0
C. diff Infection An Urgent Threat Phase 2 Posted on October 8, 2021 (October 21, 2021) by vakilspremedia in For version 2.0
Dysbiosis and C. Diff Infection Phase 2 Posted on October 8, 2021 (October 21, 2021) by vakilspremedia in For version 2.0
Importance of Microbial Diversity phase 2 Posted on October 7, 2021 (October 21, 2021) by vakilspremedia in For version 2.0
Dysbiosis & C. diff Infection Explore 2.0 Posted on September 28, 2021 (October 21, 2021) by vakilspremedia in Explore
Limitations of Current Therapeutic Options: Limitations of Current Options Explore 2.0 Posted on September 27, 2021 (October 21, 2021) by vakilspremedia in Explore

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter “Ferring”) and its various products that may be of interest to Ferring’s employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring. All information on this site is intended for US audiences only.
©2020 Ferring B.V. US-MBIO-2000006

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter “Ferring”) and its various products that may be of interest to Ferring’s employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring. All information on this site is intended for US audiences only. ©2021 Ferring B.V. US-MBIO-2100090

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter “Ferring”) and its various products that may be of interest to Ferring’s employees and customers, as well as to members of the healthcare community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring. All information on this site is intended for US audiences only. ©2021 Ferring B.V. US-MBIO-2100164This site is intended for users in the United States.

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter “Ferring”) and its various products that may be of interest to Ferring’s employees and customers, as well as to members of the healthcare community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring. All information on this site is intended for US audiences only. ©2021 Ferring B.V. US-MBIO-2100212This site is intended for users in the United States.

C. DIFF Basics
Treating C. DIFF
C. DIFF MAY COME BACK
Stories & support

Sign up

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter “Ferring”) and its various products that may be of interest to Ferring’s employees and customers, as well as to members of the healthcare community and the general public. Please feel free to browse this website. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this website, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring. All information on this site is intended for US audiences only. ©2022 Ferring B.V. US-MBIO-2100227